{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:50:26Z","timestamp":1791399026872,"version":"4.3.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Zigong Key Science and Technology Plan","award":["2023YKYXT01"],"award-info":[{"award-number":["2023YKYXT01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) is characterized by B-cell dysregulation and autoantibody production. This study aimed to characterize the alterations in peripheral blood B-cell subsets across different states of SLE and to evaluate their diagnostic value and association with specific autoantibodies.A total of 84 participants were enrolled, comprising 64 SLE patients (including 20 newly diagnosed, 27 stable, and 17 with lupus nephritis) and 20 healthy controls (HCs). Peripheral blood B-cell subsets, including na\u00efve B-cells, memory B-cells, and plasmablasts, were analyzed by flow cytometry. Their diagnostic performance was assessed using Receiver Operating Characteristic (ROC) curve analysis. Associations with anti-nuclear antibody (ANA), anti-dsDNA, and anti-Sm antibody status were also evaluated.Compared to HCs, SLE patients exhibited significant disturbances in B-cell homeostasis. The most consistent finding was a profound decrease in the absolute frequency of memory B cells across all patient groups (newly diagnosed, stable, and LN; all p\u2009&lt;\u20090.001). Newly diagnosed patients showed a significant expansion of plasmablasts (p\u2009=\u20090.017), which was less pronounced in stable and LN groups. ROC analysis demonstrated that the absolute memory B-cell frequency (memory B%) had outstanding diagnostic performance for SLE (AUC\u2009=\u20090.905, 80% sensitivity, 80% specificity). Furthermore, higher anti-nuclear antibody (ANA) titers and anti-dsDNA positivity were significantly associated with a decreased absolute na\u00efve B-cell count and an increased relative proportion of plasmablasts. Anti-Sm positivity was specifically linked to a higher plasmablast proportion (p\u2009=\u20090.006).Our findings highlight a marked disruption of peripheral B-cell subsets in SLE, particularly a persistent reduction in memory B cells and an expansion of plasmablasts in active disease. Memory B cells serve as an excellent diagnostic biomarker, while plasmablast expansion is closely associated with specific autoantibodies, underscoring the pivotal role of aberrant B-cell differentiation in SLE immunopathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-026-37415-z","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:25:09Z","timestamp":1769549109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alterations in peripheral blood B cell subsets and their clinical significance in systemic lupus erythematosus"],"prefix":"10.1038","volume":"16","author":[{"given":"Jingyuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"19","key":"37415_CR1","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1016\/j.scib.2024.04.075","volume":"69","author":"M Li","year":"2024","unstructured":"Li, M. et al. Incidence and prevalence of systemic lupus erythematosus in urban China, 2013\u20132017: A nationwide population-based study. Sci Bull . 69(19), 3089\u20133097. https:\/\/doi.org\/10.1016\/j.scib.2024.04.075 (2024).","journal-title":"Sci Bull ."},{"issue":"10188","key":"37415_CR2","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/s0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan, L., O\u2019Dwyer, T. & Petri, M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393(10188), 2332\u20132343. https:\/\/doi.org\/10.1016\/s0140-6736(19)30237-5 (2019).","journal-title":"Lancet"},{"issue":"11","key":"37415_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/ard-2024-225727","volume":"83","author":"G Schett","year":"2024","unstructured":"Schett, G., Nagy, G., Kr\u00f6nke, G. & Mielenz, D. B-cell depletion in autoimmune diseases. Ann Rheum Dis. 83(11), 1409\u20131420. https:\/\/doi.org\/10.1136\/ard-2024-225727 (2024).","journal-title":"Ann Rheum Dis."},{"issue":"22","key":"37415_CR4","doi-asserted-by":"publisher","first-page":"e939","DOI":"10.1097\/md.0000000000000939","volume":"94","author":"YM Zhang","year":"2015","unstructured":"Zhang, Y. M. et al. Rare Variants of ATG5 Are Likely to Be Associated With Chinese Patients With Systemic Lupus Erythematosus. Medicine (Baltimore) 94(22), e939. https:\/\/doi.org\/10.1097\/md.0000000000000939 (2015).","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"37415_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer, M. et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 78(9), 1151\u20131159. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819 (2019).","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"37415_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65(2), 521\u2013530. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00443.x (2004).","journal-title":"Kidney Int."},{"issue":"1","key":"37415_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan, L., Lu, M. P., Wang, J. H., Xu, M. & Yang, S. R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 16(1), 19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3 (2020).","journal-title":"World J Pediatr."},{"issue":"7","key":"37415_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1080\/15548627.2015.1052206","volume":"11","author":"CG Weindel","year":"2015","unstructured":"Weindel, C. G. et al. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy 11(7), 1010\u20131024. https:\/\/doi.org\/10.1080\/15548627.2015.1052206 (2015).","journal-title":"Autophagy"},{"issue":"9","key":"37415_CR9","doi-asserted-by":"publisher","first-page":"e1416","DOI":"10.1038\/cddis.2014.375","volume":"5","author":"H Fan","year":"2014","unstructured":"Fan, H. et al. Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus. Cell Death Dis. 5(9), e1416. https:\/\/doi.org\/10.1038\/cddis.2014.375 (2014).","journal-title":"Cell Death Dis."},{"issue":"2","key":"37415_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/08916934.2019.1700232","volume":"53","author":"Y Feng","year":"2020","unstructured":"Feng, Y., Yang, M., Wu, H. & Lu, Q. The pathological role of B cells in systemic lupus erythematosus: From basic research to clinical. Autoimmunity 53(2), 56\u201364. https:\/\/doi.org\/10.1080\/08916934.2019.1700232 (2020).","journal-title":"Autoimmunity"},{"issue":"20","key":"37415_CR11","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.1111\/jcmm.15836","volume":"24","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Altered frequency of peripheral B-cell subsets and their correlation with disease activity in patients with systemic lupus erythematosus: A comprehensive analysis. J Cell Mol Med. 24(20), 12044\u201312053. https:\/\/doi.org\/10.1111\/jcmm.15836 (2020).","journal-title":"J Cell Mol Med."},{"issue":"12","key":"37415_CR12","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/leu.2016.226","volume":"30","author":"M Seifert","year":"2016","unstructured":"Seifert, M. & K\u00fcppers, R. Human memory B cells. Leukemia 30(12), 2283\u20132292. https:\/\/doi.org\/10.1038\/leu.2016.226 (2016).","journal-title":"Leukemia"},{"issue":"1","key":"37415_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10067-017-3877-1","volume":"37","author":"L Zhu","year":"2018","unstructured":"Zhu, L. et al. Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients. Clin Rheumatol. 37(1), 205\u2013212. https:\/\/doi.org\/10.1007\/s10067-017-3877-1 (2018).","journal-title":"Clin Rheumatol."},{"issue":"8","key":"37415_CR14","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.immuni.2024.05.022","volume":"57","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. High recallability of memory B cells requires ZFP318-dependent transcriptional regulation of mitochondrial function. Immunity 57(8), 1848-1863.e7. https:\/\/doi.org\/10.1016\/j.immuni.2024.05.022 (2024).","journal-title":"Immunity"},{"issue":"6","key":"37415_CR15","doi-asserted-by":"publisher","first-page":"108684","DOI":"10.1016\/j.celrep.2020.108684","volume":"34","author":"HJ Sutton","year":"2021","unstructured":"Sutton, H. J. et al. Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans. Cell Rep. 34(6), 108684. https:\/\/doi.org\/10.1016\/j.celrep.2020.108684 (2021).","journal-title":"Cell Rep."},{"issue":"6415","key":"37415_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.aap9310","volume":"362","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. Science 362(6415), 700\u2013705. https:\/\/doi.org\/10.1126\/science.aap9310 (2018).","journal-title":"Science"},{"key":"37415_CR17","doi-asserted-by":"publisher","first-page":"102861","DOI":"10.1016\/j.jaut.2022.102861","volume":"132","author":"H Lou","year":"2022","unstructured":"Lou, H., Ling, G. S. & Cao, X. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target. J Autoimmun. 132, 102861. https:\/\/doi.org\/10.1016\/j.jaut.2022.102861 (2022).","journal-title":"J Autoimmun."},{"issue":"1","key":"37415_CR18","doi-asserted-by":"publisher","first-page":"37213","DOI":"10.1038\/s41598-025-21039-w","volume":"15","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. Analytical and clinical comparison of four SLE-associated autoantibodies in different autoimmune diseases. Sci Rep. 15(1), 37213. https:\/\/doi.org\/10.1038\/s41598-025-21039-w (2025).","journal-title":"Sci Rep."},{"key":"37415_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09513-x","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus. Nature https:\/\/doi.org\/10.1038\/s41586-025-09513-x (2025).","journal-title":"Nature"},{"issue":"6","key":"37415_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.autrev.2009.01.007","volume":"8","author":"D Cornec","year":"2009","unstructured":"Cornec, D., Avouac, J., Youinou, P. & Saraux, A. Critical analysis of rituximab-induced serological changes in connective tissue diseases. Autoimmun Rev. 8(6), 515\u2013519. https:\/\/doi.org\/10.1016\/j.autrev.2009.01.007 (2009).","journal-title":"Autoimmun Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37415-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:06:07Z","timestamp":1770977167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37415-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37415-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Zigong First People\u2019s Hospital (NO.03202024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6293"}}